Effective and timely prevention of acute ischemic stroke (AIS) is characterized by a rising socio-medical importance as this is the most common cerebrovascular disease worldwide and in Bulgaria as well. Our purpose was to reveal the incidence rate of the disorders of glucose metabolism in AIS development among adult patients.
INTRODUCTION
Acute ischemic stroke (AIS) is the most common cerebrovascular disease worldwide and in Bulgaria as well. The disorders of glucose metabolism are a recognized risk factor for AIS. Besides diabetes mellitus represents an unfavourable prognostic factor for AIS patients (1) . Patients with diabetes mellitus have approximately twice the risk of AIS compared to those without this disease (2) . Metabol-ic pathology in diabetes mellitus causes cerebral arterial dysfunction and that is why such patients require proper management of any metabolic disorders in order to reduce atherogenesis (3) . Serial blood glucose measurements might be a better predictor of clinical outcome in AIS patients treated with intravenous thrombolysis than single ones before this treatment (4) . Hyperglycaemia is a strong risk factor for poor outcome after AIS, but it may be simply a marker of poor outcome rather than a cause. Glucose lowering does not relate to improved prognosis of the disease.
MATERIAL AND METHODS
Our investigation covered 129 male and 129 female patients with AIS at a mean age of 70.59±7.22 years hospitalized in the First Clinic of Neurology, St. Marina University Hospital of Varna in 2007-2013. Fasting blood glucose concentrations at admission were examined and analyzed according to gender and number of accompanying cardiovascular diseases (CVDs) or pathological conditions. In 2013, glycated hemoglobin values were estimated in 12 AIS patients, seven males and five females, too. Statistical data processing was performed by variation (ANOVA as t-criterion was considered significant if p<0.05) analysis and correlation (Pearson's coefficient) analysis as well. SPSS, version 13.0 software was used.
RESULTS
Mean blood glucose concentrations vary in relatively broad limits (between 6.14 mmol/L in 2010 and 7.97 mmol/L in 2013) ( Table 1) . Total blood glucose values are higher in males than in females except for the minimal value.
The analysis of the number and relative share of the patients with normal, decreased and increased blood glucose values displays the frequency of anomalies and thus illustrates the importance of regular examinations under outpatient conditions for preventive purposes (Table 2 and Table 3 ). The males with abnormally elevated values present with higher mean and maximal values than the females. Besides the range between the maximal concentration in the cases with pathologically increased blood glucose values and its minimal concentration in the cases with pathologically decreased blood glucose values is broader in the male than in the female patients (14.70 There is moderate positive correlation between the level of blood glucose and the preceding diabetes mellitus (r=0.431) as well as a strong one between this level and the newly-diagnosed diabetes mellitus (r=0.733) among our AIS patients (Table 4 ). This demonstrates that the disorders of glucose metabolism are associated with the occurrence of AIS, especially in males.
The blood glucose values of AIS patients presenting with at least one out of nine accompanying CVDs or pathological conditions have been analyzed. These nosologic units are the following: arterial hypertension, hypertensive heart, coronary atherosclerosis, ischemic heart disease, effort angina pectoris, myocardial infarction, atrial fibrillation, ventricular tachyarrhythmia, and heart failure. It should be noted that there is no CVD in one male patient at all while one female patient presents with eight accompanying CVDs ( Table 5 ). The males with four and two other diseases each as well as the females with two and seven other diseases each present with the highest mean blood glucose concentrations.
These findings support the relationship between diabetes mellitus and CVDs as proved risk factors for AIS in adulthood.
DISCUSSION
Hyperglycaemia relates to poor prognosis of AIS. It is an indicator of severe AIS that can't enhance the glucose concentration in the brain. However, it further promotes cerebral ischemia. The cerebral glucose concentration controlled by the cerebral glucose transporters contributes to the energy supply to the brain, especially among AIS patients, and could become a therapeutic target for IS (5 (6) . A randomized, blinded efficacy trial outlines the potential benefits and risks of standard versus intensive hyperglycaemia management in AIS patients (7) . The detrimental effects of hyperglycaemia on the morbidity and mortality of AIS patients during the initial 48 hours of the disease were emphasized (8) . A study of 2 639 IS patients in China shows that impaired glucose regulation as assessed by the glucose tolerance test is an independent risk factor for their one-year mortality (p=0.006) and should be highlighted and intervened actively in such patients (9) . Hyperglycaemia is commonly encountered in patients with or without diabetes mellitus in AIS. The evidence links it with neurotoxicity coupled with the failure of intensive glucose control regimens to improve functional outcomes in AIS and suggests that novel approaches should be devised. Glycaemic variability was a proven predictor of prognosis in critically ill AIS patients (10) .
Admission hyperglycaemia was very common in AIS patients and was related to worse prognosis in non-lacunar brain infarction. The association between hyperglycaemia and clinical outcome in 689 consecutive lacunar AIS patients in a hospitalized Chinese population was investigated (11) . Of them, 159 (23%) presented with diabetes mellitus. In non-lacunar AIS, admission hyperglycaemia was independently associated with increased risk of poor outcome (p=0.0005) while in lacunar AIS, it was not related to functional outcome at one year (p=0.086) irrespective of the diabetic status. Chronic hyperglycemia aggravated haemorrhagic transformation after stroke through mitochondrial dysfunction and morphological alteration (12) .
The prevalence of prediabetes mellitus, an intermediate metabolic state between normal glucose metabolism and diabetes mellitus, in previously nondiabetic patients with a recent AIS ranges from 23 to 53% and represents undiagnosed abnormal glucose metabolism. This pathology seems to be a modest predictor for AIS, but doubles the risk for recurrent disease. It could become one of the most important modifiable therapeutic targets in both primary and secondary prevention (13) .
The retrospective analysis of a prospective series of first-ever AIS patients revealed that the patients with prediabetes mellitus presented more commonly with arterial hypertension (p=0.006) and higher waist circumference (p<0.0001) than those without diabetes mellitus, and diabetes mellitus patients had more hypercholesterolemia (p<0.0001), coronary artery disease (p=0.005) and higher body mass index (p=0.017) than those with prediabetes (14) .
The investigation of 1 316 AIS patients without previous diabetes mellitus in China demonstrated that the combination of glycated hemoglobin and fasting plasma glucose increased the diagnostic rate of diabetes mellitus when compared with oral glucose tolerance test as well as with glycated hemoglobin or fasting plasma glucose alone. The glycated hemoglobin could significantly detect more cases of prediabetes than the oral glucose tolerance test (p<0.001) (15) . The glycated hemoglobin ≥7.2% (>55 mmol/mol) was an independent risk predictor for one-year all-cause mortality after first-ever AIS (16) .
Among 1052 AIS patients without diabetes mellitus, hazard ratio for AIS was 1.04 (95% CI 0.83-1.30) for the lowest glycated hemoglobin quartile (<6.35%) and 1.63 (95% CI 1.33-2.00) for the highest quartile (>7.70%) (for trend, p<0.001) while in 11 176 AIS patients with diabetes mellitus, it was 1.17 (95% CI 1.09-1.26) for every 1% increment in glycated hemoglobin level (17) .
In 140 out of 242 consecutive AIS patients without previously diagnosed diabetes mellitus, the disease was proved by means of glucose tolerance test at admission (18) . In multivariate analysis, the risk of early neurological deterioration was significantly higher in these patients than in those with normal glucose tolerance (p=0.019) while the risk of poor outcome was more significantly higher (p<0.001), even after adjusting for confounding factors (p=0.008).
In a population-based study in Greater Cincinnati/Northern Kentucky region, a rising incidence of the history of diabetes mellitus among first IS patients -from 28% in 1993/1994 to 29% in 1999 and 33% in 2005 was reported (19) . Risk ratios for rates of IS among the patients with versus without diabetes mellitus for blacks reduced significantly from 5.6 in 1993/1994 to 3.2 in 2005. They varied with age, with an overall 5-to 14-fold increased risk among the patients aged 20 to 65 years. Diabetes mellitus or impaired fasting glucose in young AIS survivors was frequent and was associated with recurrent vascular events. Regular screening yielded potential for secondary AIS prevention (20) . Type 2 diabetes mellitus was present in 32.2% of 482 AIS patients at a mean age of 78.8±6.7 years (21) . AIS patients with diabetes mellitus should not be excluded from intravenous thrombolysis as it was independently associated with a lower risk of poor outcome in such patients (p=0.002) (22) .
CONCLUSION
The results from the present study and the recent literature data available illustrate the effect of the common disorders of glucose metabolism such as hyperglycaemia, prediabetes and diabetes mellitus on the development of AIS in adult patients. We could draw the conclusion that the regular control of blood glucose by the general practitioners and the promotion of the healthy life-style in CVD patients could successfully contribute to the prevention of AIS in Bulgaria.
